Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Therapy for AML with Myelodysplasia-Related Changes (AML-MRC)

Taiichi Kyo, MD, Kouhei Kyo, MD, Takeshi Okatani, MD, Tetsuro Ochi, MD, Kayo Toishigawa, Ryota Imanaka, MD, Yuta Katayama, MD PhD, Mitsuhiro Itagaki, MD

Blood (2015) 126 (23): 1340.

https://doi.org/10.1182/blood.V126.23.1340.1340

Published: 2015

Journal Articles

A High Incidence of Disseminated Intravascular Coagulation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia and Its Management

Ryota Imanaka, MD, Taiichi Kyo, MD, Kayo Toishigawa, MD, Tetsuro Ochi, MD, Takeshi Okatani, MD, Kouhei Kyo, MD, Mitsuhiro Itagaki, MD, Hisao Nagoshi, MD, Yuta Katayama, MD PhD, Koji Iwato, MD, Hideki Asaoku, MD

Blood (2015) 126 (23): 2500.

https://doi.org/10.1182/blood.V126.23.2500.2500

Published: 2015

Journal Articles

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation: A Multi-Center Study in Japan

Blood (2015) 126 (23): 4341.

https://doi.org/10.1182/blood.V126.23.4341.4341

Published: 2015

Journal Articles

Deep Molecular Response Achieved By Second-Generation Tyrosine Kinase Inhibitors (TKIs) Can Lead to Stopping TKIs

Tetsuro Ochi, Taiichi Kyo, MD, Kayo Toishigawa, Takeshi Okatani, Ryota Imanaka, Kohei Kyo, Mitsuhiro Itagaki, Yuta Katayama, Koji Iwato, Hideki Asaoku

Blood (2015) 126 (23): 1594.

https://doi.org/10.1182/blood.V126.23.1594.1594

Published: 2015

Journal Articles

Title in Chemotherapy for Acute Myeloid Leukemia with High Leukocyte Counts.

Taiichi Kyo, MD, Ryota Imanaka, MD, Tetsuro Ochi, MD, Takeshi Okatani, MD, Kohei Kyo, MD, Mitsuhiro Itagaki, MD, Hisao Nagoshi, MD, Yuta Katayama, MD, Koji Iwato, MD, Hideki Asaoku, MD

Blood (2014) 124 (21): 5272.

https://doi.org/10.1182/blood.V124.21.5272.5272

Published: 2014

Journal Articles

Ponatinib Safety and Efficacy in Japanese Patients with Philadelphia Positive Leukemia: Update of a Phase 1/2 Study

Taiichi Kyo, Arinobu Tojo, MD PhD, Kazuhito Yamamoto, Naoto Takahashi, Hirohisa Nakamae, Yukio Kobayashi, Tetsuzo Tauchi, Shinichiro Okamoto, Koichi Miyamura, Hiromi Iwasaki, MD PhD, Kiyohiko Hatake, MD PhD, Itaru Matsumura, Noriko Usui, Kumiko Yanase, Simin Hu, Tomoki Naoe, Kazuma Ohyashiki

Blood (2014) 124 (21): 5541.

https://doi.org/10.1182/blood.V124.21.5541.5541

Published: 2014

Journal Articles

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation

Kazuyoshi Ishii, MD MPH, PhD, Shosaku Nomura, MD PhD, Tomoki Ito, MD PhD, Yuta Katayama, MD PhD, Taiichi Kyo, MD, Shuichi Ota, MD PhD, Masanori Seki, MD PhD, Shigeru Chiba, MD PhD, Yoshinobu Maeda, MD PhD, Mitsune Tanimoto, MD PhD, Takayuki Ikezoe, MD PhD, Hideo Yagi, MD PhD, Yoji Ishida, MD, PhD, Naohito Fujishima, MD PhD, Kenichi Sawada, MDPhD

Blood (2014) 124 (21): 5089.

https://doi.org/10.1182/blood.V124.21.5089.5089

Published: 2014

Journal Articles

Treatment of AML with Myelodysplasia Related Changes(AML-MRC) By Sequential Therapy of Azacitidine (AZA) and Intensive Chemotherapy

Taiichi Kyo, MD, Kouhei Kyo, MD, Kayo Toishikawa, MD, Ryota Imanaka, MD, Tetsuro Ochi, MD, Yuta Katayama, MD, Takeshi Okatani, MD, Mitsuhiro Itagaki, MD, Koji Iwato, MD, Hideki Asaoku, MD

Blood (2014) 124 (21): 5288.

https://doi.org/10.1182/blood.V124.21.5288.5288

Published: 2014

Journal Articles

Voriconazole (VRCZ) Versus Itraconazole (ITCZ) As Antifungal Prophylaxis For Acute Myelogenus Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) Patients In Induction Therapy, Prospective Randomized Study

Kouhei Kyo, M.D., Mitsuhiro Itagaki, MD, Taiichi Kyo, MD, Takeshi Okatani, M.D., Tetsuro Ochi, Yuta Katayama, MD, PhD, Ryouta Imanaka, M.D., Kouji Iwato, Hideki Asaoku, M.D.

Blood (2013) 122 (21): 3897.

https://doi.org/10.1182/blood.V122.21.3897.3897

Published: 2013

Journal Articles

Recombinant Thrombomodurin For The Treatment Of Transplantation-Associated Coagulopathy After Allogeneic Stem Cell Transplantation

Kazuyoshi Ishii, MD, MPH, PhD, Shosaku Nomura, MD, PhD, Tomoki Ito, MD, PhD, Yuta Katayama, MD, PhD, Taiichi Kyo, MD, Shuichi Ota, MD, PhD, Masanori Seki, MD, PhD, Shigeru Chiba, MD, PhD, Yoshinobu Maeda, M.D., Ph.D., Mitsune Tanimoto, MD, PhD, Takayuki Ikezoe, MD. PhD, Hideo Yagi, MD, PhD, Yoji Ishida, M.D., Ph.D., Naohito Fujishima, MD, PhD, Kenichi Sawada, MD, PhD

Blood (2013) 122 (21): 5454.

https://doi.org/10.1182/blood.V122.21.5454.5454

Published: 2013

Journal Articles

Improvement Of The Efficacy Of Azacitidine At a Fixed Dosing Schedule Of 75mg/m 2 /Day For 5 Days, Followed By 21 Days Drug-Off In Higher Risk Myelodysplastic Syndromes

Taiichi Kyo, M.D., Kouhei Kyo, MD, Ryouta Imanaka, M.D., Mitsuhiro Itagaki, MD, Tetsuro Ochi, Takeshi Okatani, M.D., Koji Iwato, MD, Yuta Katayama, MD, PhD, Hideki Asaoku, M.D.

Blood (2013) 122 (21): 1571.

https://doi.org/10.1182/blood.V122.21.1571.1571

Published: 2013

Journal Articles

Treatment Results and Malignant Complications in Patients on Long-Term Treatment with Tyrosine Kinase Inhibitors(TKIs) for Chronic Myeloid Leukemia(CML)

Taiichi Kyo, MD, Kouhei Kyo, M.D., Takesi Okatani, Mitsuhiro Itagaki, M.D., Ryouta Imanaka, M.D., Yuuta Katayama, Kouji Iwato, Hideki Asaoku, MD, Tetsurou Ohti, Megu Ohtaki, Keiko Ohtani

Blood (2012) 120 (21): 3767.

https://doi.org/10.1182/blood.V120.21.3767.3767

Published: 2012

Journal Articles

Discontinuation of Imatinib in Japanese Patients with Chronic Myeloid Leukemia,

Naoto Takahashi, MD, PhD, Taiichi Kyo, MD, Yasuhiro Maeda, MD, PhD, Takashi Sugihara, MD, PhD, Kensuke Usuki, MD, Tatsuya Kawaguchi, MD, PhD, Noriko Usui, MD, Shinichiro Okamoto, MD, PhD, Yokiko Ohe, MD, Shigeki Ohtake, MD, PhD, Kunio Kitamura, Masahide Yamamoto, MD, Hirofumi Teshima, MD, Toshiko Motoji, MD, PhD, Toshiharu Tamaki, MD, Kenichi Sawada, MD, PhD, Kazuma Ohyashiki, MD, PhD

Blood (2011) 118 (21): 3759.

https://doi.org/10.1182/blood.V118.21.3759.3759

Published: 2011

Journal Articles

Long-Term Outcome of All-Trans-Retinoic-Acid(ATRA)+Intensive Chemotherapy in Acute Promyelocytic Leukemia(APL),

Taiichi Kyo, M.D., Takeshi Okatani, M.D., Kouhei Kyo, M.D., Mitsuhiro Itagaki, M.D., Ryouta Imanaka, M.D., Koji Iwato, M.D., Hidkeki Asaoku, M.D., Yuuta Katayama, M.D.

Blood (2011) 118 (21): 3604.

https://doi.org/10.1182/blood.V118.21.3604.3604

Published: 2011

Journal Articles

Increased NK Cells and Decreased CD3 + CD8 + CD62L + T Cells in CML Patients Who Sustained Complete Molecular Remission After Discontinuation of Imatinib

Kazuma Ohyashiki, MD, PhD, Sei-ichiro Katagiri, MD, Tetsuzo Tauchi, MD, PhD, Junko H Ohyashiki, MD, PhD, Yasuhiro Maeda, MD, PhD, Itaru Matsumura, MD, PhD, Taiichi Kyo, MD

Blood (2011) 118 (21): 1697.

https://doi.org/10.1182/blood.V118.21.1697.1697

Published: 2011

Journal Articles

Early Diagnostic Procedure and Treatment for Invasive Fungal Infection Centered on Invasive Aspergillosis in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia

Kouhei Kyo, M.D., Takeshi Okatani, M.D., Ryota Imanaka, M.D., Mitsuhiro Itagaki, M.D., Yuuta Katayama, M.D., Taiichi Kyo, M.D.

Blood (2011) 118 (21): 1544.

https://doi.org/10.1182/blood.V118.21.1544.1544

Published: 2011

Journal Articles

Results of Treatment with Tyrosine Kinase Inhibitors(TKIs) in Combination with Intensive Chemotherapy in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia(Ph+ALL)

Taiichi Kyo, M.D., Takeshi Okatani, M.D., Kouhei Kyo, Ryouta Imanaka, M.D., Mitsuhiro Itagaki, M.D., Yuuta Katayama, MD, Koji Iwato, M.D., Hideki Asaoku, MD

Blood (2011) 118 (21): 1503.

https://doi.org/10.1182/blood.V118.21.1503.1503

Published: 2011

Journal Articles

Efficacy of Gemtuzumab Ozogamicin (GO) Monotherapy on Relapsed/Refractory Acute Promyelocytic Leukemia (APL)

Blood (2011) 118 (21): 1532.

https://doi.org/10.1182/blood.V118.21.1532.1532

Published: 2011

Journal Articles

Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)

Taiichi Kyo, MD, Noriaki Yoshida, MD, Kouhei Kyo, MD, Takeshi Okatani, MD, Mitsuhiro Itagaki, MD, Hiromi Yuasa, MD, Koji Iwato, MD, Hideki Asaoku, MD, Yuuta Katayama, MD

Blood (2010) 116 (21): 2934.

https://doi.org/10.1182/blood.V116.21.2934.2934

Published: 2010

Journal Articles

A Decision Analysis of Unrelated Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia In First Remission Who Lack An HLA-Matched Sibling

Blood (2010) 116 (21): 3527.

https://doi.org/10.1182/blood.V116.21.3527.3527

Published: 2010

NARROW

Therapy for AML with Myelodysplasia-Related Changes (AML-MRC)

A High Incidence of Disseminated Intravascular Coagulation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia and Its Management

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation: A Multi-Center Study in Japan

Deep Molecular Response Achieved By Second-Generation Tyrosine Kinase Inhibitors (TKIs) Can Lead to Stopping TKIs

Title in Chemotherapy for Acute Myeloid Leukemia with High Leukocyte Counts.

Ponatinib Safety and Efficacy in Japanese Patients with Philadelphia Positive Leukemia: Update of a Phase 1/2 Study

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation

Treatment of AML with Myelodysplasia Related Changes(AML-MRC) By Sequential Therapy of Azacitidine (AZA) and Intensive Chemotherapy

Voriconazole (VRCZ) Versus Itraconazole (ITCZ) As Antifungal Prophylaxis For Acute Myelogenus Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) Patients In Induction Therapy, Prospective Randomized Study

Recombinant Thrombomodurin For The Treatment Of Transplantation-Associated Coagulopathy After Allogeneic Stem Cell Transplantation

Improvement Of The Efficacy Of Azacitidine At a Fixed Dosing Schedule Of 75mg/m 2 /Day For 5 Days, Followed By 21 Days Drug-Off In Higher Risk Myelodysplastic Syndromes

Treatment Results and Malignant Complications in Patients on Long-Term Treatment with Tyrosine Kinase Inhibitors(TKIs) for Chronic Myeloid Leukemia(CML)

Discontinuation of Imatinib in Japanese Patients with Chronic Myeloid Leukemia,

Long-Term Outcome of All-Trans-Retinoic-Acid(ATRA)+Intensive Chemotherapy in Acute Promyelocytic Leukemia(APL),

Increased NK Cells and Decreased CD3 + CD8 + CD62L + T Cells in CML Patients Who Sustained Complete Molecular Remission After Discontinuation of Imatinib

Early Diagnostic Procedure and Treatment for Invasive Fungal Infection Centered on Invasive Aspergillosis in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia

Results of Treatment with Tyrosine Kinase Inhibitors(TKIs) in Combination with Intensive Chemotherapy in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia(Ph+ALL)

Efficacy of Gemtuzumab Ozogamicin (GO) Monotherapy on Relapsed/Refractory Acute Promyelocytic Leukemia (APL)

Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)

A Decision Analysis of Unrelated Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia In First Remission Who Lack An HLA-Matched Sibling

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only